Navane

Quick links to important sections

Navane

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Navane

Quick Facts

Property Description
Active ingredient Tiotixene (Thiothixene)
Form Capsules (Oral), Powder/Solution (Injection)
Pharmacological class First-Generation Antipsychotic (FGA)
Common use Management of psychotic disorders
Origin Synthetic compound

What is Navane and its Pharmacological Classification?

Navane is the trade name for the powerful, prescription-only medication whose active component is Tiotixene, a compound also referred to as Thiothixene. It is officially categorized as a first-generation antipsychotic (FGA), which belongs to the established class of neuroleptic drugs. Tiotixene is chemically defined as a thioxanthene derivative, a characteristic structure that distinguishes it from other antipsychotic classes.

Composition, Origin, and General Purpose

The medication is a single-ingredient product, with Tiotixene being the sole therapeutic agent, synthesized as a synthetic compound. It is indicated for use in adults and teenagers 12 years and older to manage severe disturbances in thought, feeling, and behavior. Its general purpose is to stabilize perceptions and moderate brain signaling pathways that contribute to disorganized thinking, providing symptomatic control essential for conditions such as psychotic disorders and schizophrenia. Clinical documentation indicates Tiotixene’s efficacy in helping to control the core positive symptoms of psychosis.

Available Forms of Tiotixene

Tiotixene is supplied in multiple pharmaceutical preparations designed to accommodate both routine and urgent care requirements. The primary dosage form(s) include oral capsules intended for regular, long-term administration. Additionally, the drug is available for intramuscular administration as a powder or solution for injection, formulations which provide essential options for rapid therapeutic intervention in acute clinical settings.

What side effects are possible with Navane?

Possible Side Effects and Safety Information

Navane (thiothixene) is a first-generation antipsychotic associated with a range of potential adverse effects, particularly those involving the central nervous system and movement.

Serious Safety Warnings

Increased Mortality in Elderly Patients with Dementia-Related Psychosis: Antipsychotic drugs in this class are associated with an increased risk of death when used to treat psychosis related to dementia. Navane is not approved for this condition.

Neuroleptic Malignant Syndrome (NMS): This is a rare, potentially fatal complex characterized by high fever (hyperpyrexia), severe muscle stiffness (rigidity), altered mental status, and autonomic instability (e.g., irregular pulse or blood pressure).

Tardive Dyskinesia (TD): A syndrome of potentially irreversible, involuntary, repetitive movements, typically of the face, tongue, and jaw, that may develop with long-term therapy.

Common and Other Adverse Reactions

Side effects frequently reported include drowsiness, which is often mild and subsides with continued treatment, extrapyramidal symptoms (EPS) such as akathisia (restlessness), pseudoparkinsonism, and acute dystonia (muscle spasms). Acute dystonia occurs more frequently with high-potency agents and higher doses.

Other notable adverse effects include blurred vision, dry mouth, constipation, nausea, vomiting, and cardiovascular effects such as orthostatic hypotension (dizziness upon standing) and nonspecific EKG changes. Hyperprolactinemia, potentially leading to galactorrhea, amenorrhea, and impotence, has also been reported.

Contraindications and Restrictions

Navane is contraindicated in patients with circulatory collapse, severe central nervous system depression, comatose states, blood cell disorders (blood dyscrasias), and documented hypersensitivity to the drug. Caution is advised for use in patients with a history of seizures or cardiovascular disease. Safety for use in children under 12 years of age has not been established. Patients should be monitored for signs of blood dyscrasias (e.g., leukopenia) and advised about the risk of increased sensitivity to sunlight (photosensitivity).

Overdose and Emergency Response

Overdose on Tiotixene is associated with the risk of severe central nervous system (CNS) and cardiovascular events, necessitating immediate action. Documented manifestations include marked CNS depression progressing from drowsiness and dizziness to coma. Severe extrapyramidal symptoms (EPS) are reported, such as muscular twitching, rigidity, torticollis, and disturbances of gait, which may lead to dysphagia. Potential life-threatening outcomes reported in regulatory documents include seizures, cardiac arrest, circulatory shock, and dangerous arrhythmias like QT prolongation and Torsade de pointe. Disturbances in thermoregulation, manifesting as hyperthermia or hypothermia, are also noted.


  • Mandated Emergency Action: Official guidance requires individuals to seek immediate medical attention for any suspected overdose. Emergency services must be contacted immediately if the person has collapsed, had a seizure, has trouble breathing, or cannot be awakened.

  • Supportive Management: Treatment is essentially symptomatic and supportive, as no specific antidote is known. Management procedures involve keeping the patient under careful observation, maintaining an open airway, and continuous cardiac monitoring. Specific regulatory constraints advise against the use of epinephrine for treating hypotension due to the risk of paradoxical effects, and recommend the use of certain antiparkinson drugs for managing severe EPS.

Therapeutic Uses of Navane

What Navane Treats: Main Uses and Benefits

Tiotixene (Navane) is generally used to help with the management of schizophrenia and other psychotic disorders, which are conditions characterized by periods of heightened symptoms and a significant symptomatic burden. The medication is applied across therapeutic domains where additional symptomatic support is needed to address symptoms related to disrupted thinking, feeling, and behavior.

It is relevant for easing challenging manifestations like hallucinations and delusions which interfere with daily functioning, and is commonly used when short-term symptomatic assistance is needed to help with the management of severe agitation. The primary indications relevant to this support include schizophrenia and acute psychosis.

For patients in long-term care, Tiotixene assists with maintaining functional stability and provides support that helps ease the overall symptom burden, contributing to improved comfort during symptomatic periods. This management may assist with addressing symptoms that create noticeable functional strain for individuals with these conditions.

“This support helps patients cope more steadily with difficult episodes by easing the intensity of distressing manifestations.”


Quick Fact: Support for Psychosis Symptoms

Property Description
Primary Use Focus Management of Schizophrenia and Psychotic Disorders
Symptom Relief Hallucinations, delusions, and severe agitation
Clinical Context Used for both support in acute symptom management and support for conditions involving recurrent manifestations
Key Benefit Contributes to easing the overall symptom load and supports functional stability

Regulatory References

  1. NIH MedlinePlus overview on Thiothixene

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Navane (Tiotixene) — Official Regulatory Information

Eligibility scope Official Regulatory Statement
Populations for whom use is allowed Approved for use in adults and teenagers 12 years of age and older.
Populations for whom use is not recommended Use is not recommended in children under 12 years of age because safe conditions for use have not been established.
Populations for whom use is contraindicated Contraindicated in patients with: circulatory collapse, comatose states, Central Nervous System (CNS) depression due to any cause, and known blood dyscrasias. Also contraindicated with known hypersensitivity to the drug.
Age-related eligibility rules Not approved for treatment of elderly patients with dementia-related psychosis (due to increased risk of death, a boxed warning).
Condition-specific eligibility rules Requires extreme caution in patients with a history of convulsive disorders or those in a state of alcohol withdrawal (may lower the seizure threshold). Use with caution in patients with cardiovascular disease or those exposed to extreme heat.
Pregnancy and lactation eligibility status Safe use during pregnancy has not been established; use is only permitted when the benefits outweigh the risks. Neonates exposed during the third trimester are at risk for extrapyramidal and/or withdrawal symptoms. Breast-feeding is not recommended.

Official Eligibility Statements

  • Tiotixene is contraindicated in patients presenting with severe conditions like circulatory collapse, coma, CNS depression, blood dyscrasias, or a known hypersensitivity to the drug.
  • The medicine is not approved for use in elderly patients with dementia-related psychosis.
  • Use is not recommended for children under 12 years of age because safety has not been established.

These classifications, derived from governmental regulatory documents, establish strict non-negotiable boundaries, defining patients who are absolutely prohibited from using the medicine and those who require conditional use or close monitoring due to age-related or comorbidity-linked risks.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Tiotixene is defined by specific pharmacokinetic (PK) and pharmacodynamic (PD) patterns documented in regulatory sources.

Pharmacokinetic Clearance Modification Co-administration with hepatic microsomal enzyme inducing agents, such as Carbamazepine, causes a significant increase in Tiotixene clearance. This official interaction reduces the drug's overall exposure, potentially leading to a decrease in expected effectiveness.

Pharmacodynamic Interactions and Functional Constraints Tiotixene carries risks for additive effects when combined with substances that affect the central nervous system or blood pressure.

Interaction Type Interacting Substance/Class Official Interaction Outcome
Additive CNS Effects CNS Depressants, Alcohol, Barbiturates Possible additive CNS depression and risk of enhanced hypotension.
Additive Anticholinergic Effects Atropine or related drugs Caution advised due to Tiotixene's weak anticholinergic properties, potentially increasing effects.
Vasopressor Contraindication Epinephrine Prohibited for use to treat Tiotixene-induced low blood pressure; causes a paradoxical further lowering of blood pressure.

Furthermore, the antiemetic properties of Tiotixene are officially noted as a constraint, as they may mask the physical signs of overdosage from toxic drugs. No mandatory timing-separation rules (e.g., 'administer X hours apart') or specific interactions with food or herbal products are explicitly documented in the official prescribing information.

Mechanism of Action

Navane: Mechanism of Action (Tiotixene)

Navane's action is governed by its function as a high-affinity antagonist across multiple neurotransmitter receptor systems, predominantly within the central nervous system (CNS). This molecular activity translates into two key mechanistic domains.

Antagonizing Dopamine and Serotonin Receptors

Tiotixene exerts its primary effect via the blockade of the postsynaptic Dopamine D2 receptor and the Serotonin 5- HT2A receptor, particularly in the mesolimbic pathway. This antagonism suppresses signal transduction normally mediated by these transmitters, resulting in reduced functional throughput in these central neural circuits.

Non-Selective Receptor Affinity and Pathway Effects

This domain describes the physiological changes resulting from the drug's non-selective affinity. The D2 blockade extends to the nigrostriatal pathway, affecting the basal ganglia's control over motor coordination. Concurrently, antagonism at the Alpha-1 (alpha1) adrenergic receptor modulates systemic vascular tone via the autonomic nervous system, while affinity for the Histamine H1 receptor contributes to the drug's broader functional profile.

Dosage and Administration Information

How to Use Navane (Thiothixene) — Official Administration Guidelines

Navane (thiothixene) is an antipsychotic medication. Its proper use must strictly adhere to the instructions defined in official product labeling to ensure correct administration and dosing.


Approved Forms and Administration Routes

Form Route of Administration
Capsules Oral
Oral Concentrate Oral
Intramuscular Injection Intramuscular (IM)

Standard Dosing and Schedule

Navane dosing is highly individualized. Treatment typically begins with a divided daily dose, which is gradually adjusted by a healthcare professional.

  • Initial Oral Dosing: For milder conditions, the starting dose is often 2 mg three times daily (TID). For more severe conditions, it may start at 5 mg twice daily (BID).
  • Optimal Range: The usual optimal daily dosage generally falls between 20 mg and 30 mg.
  • Maximum Limit: The total daily dosage should not exceed 60 mg.
  • Maintenance: Once the desired response is achieved, the dose is reduced to the lowest effective maintenance level, which may sometimes be administered once daily.

Administration Requirements

Condition Instruction
Timing with Meals Can be taken with or without food
Discontinuation Should not be stopped abruptly; dosage must be gradually reduced
Pediatric Use Not generally recommended for children under 12 years of age

For the oral concentrate, note that the formulation contains alcohol. Dosage adjustments are typically necessary for geriatric patients and must be determined by a clinician.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Navane (Thiothixene)

The research record for thiothixene, the active ingredient in Navane, consists of clinical evaluations that primarily focused on conditions characterized by periods of heightened symptoms. This evidence is rooted in studies, systematic reviews, and meta-analyses, consistent with its classification as a first-generation antipsychotic agent.


Evidence for Symptom Management in Schizophrenia

Research exploring thiothixene's use in schizophrenia includes short-term Randomized Controlled Trials (RCTs) as primary evidence. These studies were used in research exploring how core symptoms change over time in adults and, in some cases, in teenagers 12 years of age and older.

  • What Researchers Studied: Studies monitored outcomes related to symptom intensity or variability using standardized psychiatric rating scales. They were applied in studies examining short-term or episodic symptom patterns, typically over follow-up durations of a few weeks up to several months. These trials primarily compared thiothixene to a placebo (an inactive substance) and to other conventional antipsychotic drugs.
  • What Remains Uncertain: A significant portion of the primary controlled evidence for thiothixene is historical. This means the evidence quality varies across studies and comparative evidence against the current generation of most commonly used antipsychotic drugs is limited.

Long-Term Studies and Follow-Up

For conditions marked by functional limitations and the potential for recurrence, research has been conducted beyond the initial phase to understand long-term patterns.

  • Evidence Contributions: The evidence landscape includes information related to continuous maintenance for psychotic disorders, which studies monitored alongside general antipsychotic class data. Findings describe patterns observed when maintenance protocols were compared to discontinuation protocols.
  • Long-Term Effects are Not Fully Established: While class evidence exists for maintenance, long-term outcomes that specifically characterize the effects of thiothixene beyond a year are not fully established. Follow-up durations were limited in many of the key trials.

Evidence in Specific Populations

Research findings and regulatory summaries provide context for certain age groups, while data for other groups remain insufficient.

  • Older Adults and Dementia: Authoritative sources clearly note that thiothixene was not studied or approved for use in older adults experiencing behavioral problems related to dementia.
  • Pregnancy and Breastfeeding: The research available for these specific populations is limited, and studies exploring the long-term effects of exposure in utero on infant development are limited.

Key Studies & References

  1. Thiothixene (MedlinePlus Drug Information) - FDA Special Warnings and Indications

Frequently Asked Questions (FAQ)

Common questions about Navane (FAQ)


Q: Is it normal to feel drowsy or sleepy when taking Navane?

A: Yes, regulatory documents list drowsiness as a commonly reported side effect of Navane. This effect is part of the drug’s impact on the central nervous system (CNS). Official information suggests that this side effect is often mild and may lessen over time as treatment continues.


Q: Can Navane interact with supplements like St. John's Wort?

A: The official product information states that co-administration with substances known as hepatic microsomal enzyme inducing agents can increase the clearance of Navane. While St. John’s Wort is not specifically named in regulatory documents, the principle of hepatic enzyme interaction may apply to substances beyond those explicitly named in the regulatory materials.


Q: What are the potential effects of Navane on memory?

A: Navane has some weak anticholinergic properties and its action affects the central nervous system (CNS). Adverse effects related to CNS function, such as difficulty with thinking and concentrating, have been reported. Effects like blurred vision and dry mouth, which are linked to the drug's anticholinergic activity, may also occur.


Q: Can Navane cause weight gain?

A: According to official regulatory documentation, weight gain is reported as a possible adverse reaction. This may sometimes be accompanied by an increase in appetite, which has also been observed in some patients taking the medication.


Q: Does Navane affect liver function?

A: Official medical information notes that some patients have experienced temporary increases in certain liver enzymes. The prescribing information also advises that caution is warranted when Navane is used by patients who have existing liver impairment.


Q: Is Navane used for anxiety or just psychosis?

A: Navane is officially approved for the management of psychotic disorders and schizophrenia. The official prescribing information published by regulatory bodies does not list anxiety disorders as an approved indication for this medication.


Q: How quickly does Navane usually start working after the first dose?

A: Official medical information indicates that the initial therapeutic response may begin to be observed within a range of 2 to 4 weeks of starting therapy. Individual responses can vary widely.


Q: When should I expect to notice the full effects of Navane?

A: Achieving the optimal therapeutic response can take an extended period. Some authoritative sources indicate that the full therapeutic effect of Navane may take up to 6 months or longer to become fully apparent.


Q: Can Navane interact with over-the-counter cold medicines?

A: Navane may have additive CNS depressant effects and anticholinergic effects when combined with other medicines that share these properties. Because many over-the-counter cold medicines contain ingredients classified as CNS depressants or having anticholinergic action, the potential for additive effects must be considered in this context.


Q: Is Navane addictive or habit-forming?

A: Authoritative sources confirm that Navane is not classified as a controlled substance and is not addictive or habit-forming. However, abrupt discontinuation of the medication is officially not advised, as it may cause a return of symptoms or other reactions.


Q: Does Navane change personality or mood in general?

A: The purpose of Navane, according to official documents, is for the management of severe disturbances in thought, feeling, and behavior. The medication works by helping to stabilize brain signaling pathways to control the symptoms of the conditions for which it is indicated.


Q: Is Navane used in the treatment of bipolar disorder?

A: Navane is officially indicated for the management of psychotic disorders, primarily schizophrenia. Medical reference resources may mention the use of Navane in conditions other than schizophrenia that involve psychotic features, but official documents focus on its approved indication.


Q: Does taking Navane mean I have a severe mental health condition?

A: The official purpose of Navane is for the management of severe disturbances in thought, feeling, and behavior. These symptoms are characteristic of the conditions, such as schizophrenia and other psychotic disorders, for which the drug is indicated.


Q: Are there any specific foods or drinks to avoid while taking Navane?

A: Official prescribing information advises that an increased effect of CNS depression may occur with the use of alcohol, so caution is warranted. Additionally, it is noted that the oral concentrate formulation of Navane contains alcohol.


Q: Can Navane cause changes to vision?

A: Yes, blurred vision is listed among the reported adverse reactions. Furthermore, regulatory sources note that this class of antipsychotic drugs has been associated with other ocular issues, including changes to eye pigmentation.


Q: Are there long-term health risks associated with taking Navane?

A: Official safety warnings indicate that long-term therapy carries the risk of developing Tardive Dyskinesia (TD), a syndrome of involuntary and potentially irreversible movements. The drug is also associated with other serious conditions, such as Neuroleptic Malignant Syndrome (NMS).


Q: What are the guidelines regarding Navane and people with kidney issues?

A: Official medical information advises that Navane should be used with caution in patients who have renal (kidney) impairment. This is done to ensure proper management given the individual's existing health status.


Q: Is Navane often used as a first-line treatment?

A: Navane is classified as a first-generation antipsychotic. As such, its clinical use in the sequence of therapy is highly dependent on the individual situation and evolving treatment guidelines.


Q: How often do people need to adjust their dosage of Navane?

A: Dosage of Navane is highly individualized. It is initially and gradually adjusted by a healthcare professional based on the individual's unique response to the medication and the severity of the condition being managed.

How should Navane be stored and disposed of?

How to Store and Dispose of Navane?

Navane (Thiothixene) must be stored and handled according to specific regulatory requirements to ensure product stability and safety.

Official Storage Conditions

The medication must be stored at Controlled Room Temperature, typically between 68 F and 77 F (20 C and 25 C). It is mandatory to keep the product away from heat, moisture, and direct light.

Storage Requirement Rule
Temperature Controlled Room Temperature
Container Tight, light-resistant, and closed
Prohibited Do not freeze; store away from heat and moisture

Stability and Child Safety

The powder for injection, once reconstituted, must be used within 48 hours and stored at room temperature. For safety, the product must be kept out of the sight and reach of children and away from pets.

Official Disposal Rules

Expired or unused Navane must be properly discarded. It is restricted from being flushed down the toilet or poured into a drain (not on the FDA Flush List). The recommended disposal method, if a take-back program is unavailable, is to mix the medicine with an unappealing substance, seal it in a container, and discard it in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Navane found in:

A-Z Index: